Tumor cells can develop resistance to treatment through various mechanisms. They can mutate target proteins, activate alternative signaling pathways, enhance drug efflux, and repair drug-induced DNA damage. This resistance poses a significant challenge in cancer treatment, often necessitating combination therapies or the development of new drugs.
